Bruce F Israel

University Of North Carolina Chapel Hill

$410,520

Attributed

$410,520

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$410,520 · 2

By mechanism

K23$408,935 · 1

M01$1,585 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Top investigators on “Neoplasm /Cancer Radiation Therapy”

Charles A Coltman · Southwest Oncology Group$65,101,418
Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
Philip J Disaia · University Of California Irvine$47,533,330
Walter J Curran · Thomas Jefferson University$41,640,321
Samuel A Wells · Duke University$32,148,803
John H. Glick · University Of Pennsylvania$26,662,963

Research focus

Neoplasm /Cancer Radiation TherapyAids Related Neoplasm /CancerVirus Related Neoplasm /CancerClinical ResearchClinical Trial Phase IHuman SubjectHuman Therapy EvaluationNeoplasm /Cancer ChemotherapyNeoplasm /Cancer TransplantationPatient Oriented ResearchScid MouseTechnology /Technique DevelopmentRecombinant VirusAdenoviridaeCombination Cancer TherapyEpstein Barr VirusGanciclovirGene TherapyCentral Nervous System NeoplasmsPolymerase Chain ReactionLymphomaAids TherapyAidsCombination Therapy

Grant awards (5)

Therapeutic Induction of the EBV Lytic Cycle in Tumors$31,457

K23 · FY2005 · AI

Therapeutic Induction of the EBV Lytic Cycle in Tumors$125,826

K23 · FY2004 · AI

LCCC-0105: USING RADIATION AND VALGANCICLOVIR TO TREAT LYMPHOMAS IN AIDS$1,585

M01 · FY2004 · RR

Therapeutic Induction of the EBV Lytic Cycle in Tumors$125,826

K23 · FY2003 · AI

Therapeutic Induction of the EBV Lytic Cycle in Tumors$125,826

K23 · FY2002 · AI